Wix.com to Present at the UBS Global Technology Conference
Nov 03, 2016 12:00 pm UTC| Business
NEW YORK, Nov. 03, 2016 -- Wix.com Ltd. (Nasdaq:WIX) announced today that Joe Pollaro, General Manager, US will present at the UBS Global Technology Conference in San Francisco on Tuesday, November 15, 2016 at 1:30 p.m....
Nov 03, 2016 12:00 pm UTC| Business
SAN DIEGO, Nov. 03, 2016 -- Neothetics, Inc. (NASDAQ:NEOT) today announced that it will provide a business update and release its third quarter 2016 financial results before the market opens on Thursday, November 10,...
Nov 03, 2016 12:00 pm UTC| Business
LAWRENCEVILLE, N.J., Nov. 03, 2016 -- Celsion Corporation (NASDAQ:CLSN) announced today that the Company will host a conference call to discuss financial results for the quarter and nine-month period ended September 30,...
Hooper Holmes Announces 2016 Third Quarter Financial Release Date and Conference Call Information
Nov 03, 2016 12:00 pm UTC| Business
OLATHE, Kan., Nov. 03, 2016 -- Hooper Holmes (NYSE MKT:HH) today announced that it will release 2016 third quarter financial results before the market opens on Thursday, November 10, 2016. The Company will host a...
Consolidated Communications Reports Third Quarter 2016 Results
Nov 03, 2016 12:00 pm UTC| Business
Grew commercial and carrier data and transport revenue by 5.2% year over yearDelivered another strong quarter of data connections led by growth in Metro EthernetCompleted a refinancing reducing interest expense, extending...
Cartesian Sets Third Quarter 2016 Conference Call for Thursday, November 10, 2016 at 4:30 p.m. ET
Nov 03, 2016 12:00 pm UTC| Business
OVERLAND PARK, Kan., Nov. 03, 2016 -- Cartesian™ (NASDAQ:CRTN), a leading provider of consulting services and managed solutions to the global communications, technology and digital media industries, will hold a...
Selecta Biosciences to Report Third Quarter 2016 Financial Results on Thursday, November 10
Nov 03, 2016 12:00 pm UTC| Business
WATERTOWN, Mass., Nov. 03, 2016 -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage biopharmaceutical company developing a novel class of targeted antigen-specific immune therapies, announced today that it...